# Labeling for Human Prescription Drug and Biological Products - Implementing the PLR Content and Format Requirements - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-human-prescription-drug-and-biological-products-implementing-the-plr-content-and-format-requirements/c135cd21-e316-4f76-b282-cd06416c3081

> FDA guidance document: Labeling for Human Prescription Drug and Biological Products - Implementing the PLR Content and Format Requirements. Issue date: February 25, 2013. Get complete insights and analysis.

---

## Details

- Title: Labeling for Human Prescription Drug and Biological Products - Implementing the PLR Content and Format Requirements
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2013-02-25
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2005-D-0153">FDA-2005-D-0153</a>

## Related Documents

- [Q8(R2) Pharmaceutical Development](https://www.globalkeysolutions.net/guidances/guidance-document/q8r2-pharmaceutical-development/952b87d6-d764-4049-94ad-25d668f24c35)
- [S9 Nonclinical Evaluation for Anticancer Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals/0d1f71ec-dd43-4c57-befe-2d7eb7e145f2)
- [Providing Submissions in Electronic Format – Postmarket Non-Expedited ICSRs Technical Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/providing-submissions-in-electronic-format-postmarket-non-expedited-icsrs-technical-questions-and-answers/16f47a81-0aba-4e45-ab3e-9a1e415cb4d4)